European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System
"We are extremely pleased by the court's verdict which reinforces a clinical team's right to select the radiation therapy system they feel best meets the needs of their facility, team and patients," said Lionel Hadjadjeba, MD, Senior Vice President and Chief Commercial Officer at
The Court of Appeal has confirmed the CHU Tours decision on all points, concluding that:
- The tender award in favor of TomoTherapy Europe should not be cancelled;
- The medical needs expressed by CHU Tours were well-defined in the administrative documents of the tender;
- The TomoTherapy System is the only radiation therapy device which provides continuous helical delivery of radiation from 360 degrees around the patient, a unique method for delivering image-guided IMRT which enables clinicians to modulate the dose in an optimal way and to irradiate large fields without repositioning the patient;
- This technique, which enables clinicians to modulate the dose in an optimal way and to irradiate large fields without repositioning the patient, is expressly recommended by the
French National Authority for Health (HAS) for craniospinal irradiations, often used in pediatric tumors, and for total body irradiation in the treatment of blood tumors.
About
Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited, to clinical applications and
Forward-looking statements speak only as of the date the statements are made and are based on information available to
View original content with multimedia:http://www.prnewswire.com/news-releases/european-court-of-appeal-rejects-varians-attempt-to-reverse-customer-purchase-of-accuray-tomotherapy-system-300539460.html
SOURCE
Beth Kaplan; Public Relations Director, Accuray; +1 (408) 789-4426; bkaplan@accuray.com OR Sherry Feldberg; MSLGROUP; +1 (781) 684-0770; accuray@mslgroup.com